Home/Filings/4/0001225208-25-009137
4//SEC Filing

Dahl Andrew M. 4

Accession 0001225208-25-009137

CIK 0001099800other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 7:52 PM ET

Size

5.2 KB

Accession

0001225208-25-009137

Insider Transaction Report

Form 4
Period: 2025-11-13
Dahl Andrew M.
SVP, Corporate Controller
Transactions
  • Award

    Common Stock

    2025-11-13+1,1609,183.074 total
Footnotes (1)
  • [F1]These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0002022347

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 7:52 PM ET
Size
5.2 KB